Treatment of renal cell carcinoma: Current status and future directions.
about
Genetic polymorphisms associated with adverse reactions of molecular-targeted therapies in renal cell carcinoma.Novel insights into biomarkers associated with renal cell carcinoma.Basic Parameters of Blood Count, Serum Sodium, and Creatinine as Prognostic Factors for Renal Cell Carcinoma at Five-Year Follow-Up.The expression and function of RASAL2 in renal cell carcinoma angiogenesisClinicopathologic Significance of Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and ReviewIntegrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma
P2860
Treatment of renal cell carcinoma: Current status and future directions.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Treatment of renal cell carcinoma: Current status and future directions.
@en
Treatment of renal cell carcinoma: Current status and future directions.
@nl
type
label
Treatment of renal cell carcinoma: Current status and future directions.
@en
Treatment of renal cell carcinoma: Current status and future directions.
@nl
prefLabel
Treatment of renal cell carcinoma: Current status and future directions.
@en
Treatment of renal cell carcinoma: Current status and future directions.
@nl
P2860
P356
P1433
P1476
Treatment of renal cell carcinoma: Current status and future directions.
@en
P2093
Brian I Rini
P2860
P304
P356
10.3322/CAAC.21411
P407
P577
2017-09-29T00:00:00Z